MONOMORPHIC EPITHELIALTROPIC INTESTINAL LYMPHOMA

Clinical trials for MONOMORPHIC EPITHELIALTROPIC INTESTINAL LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new MONOMORPHIC EPITHELIALTROPIC INTESTINAL LYMPHOMA trials appear

Sign up with your email to follow new studies for MONOMORPHIC EPITHELIALTROPIC INTESTINAL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Gene therapy trial aims to turn Patients' own cells against rare, aggressive cancers

Disease control Recruiting now

This early-stage trial is testing the safety of a new gene therapy for adults with certain T-cell lymphomas that have returned or not responded to prior treatments. Doctors will collect a patient's own immune cells, genetically modify them in a lab to target a protein (CCR4) foun…

Matched conditions: MONOMORPHIC EPITHELIALTROPIC INTESTINAL LYMPHOMA

Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Apr 01, 2026 14:42 UTC

MONOMORPHIC EPITHELIALTROPIC INTESTINAL LYMPHOMA

Get alerted when new MONOMORPHIC EPITHELIALTROPIC INTESTINAL LYMPHOMA trials appear

Gene therapy trial aims to turn Patients' own cells against rare, aggressive cancers